Abstract
Purpose
People with a history of breast cancer are at risk of losing function during and after treatment. Unfortunately, little is known about the individual and additive effects of specific treatment, disease-related, and demographic factors that may contribute to functional decline. This manuscript reports the results of a multi-center study to evaluate the effects of these factors on function.
Methods
In this cross-sectional study, women with a history of breast cancer referred to physical medicine and rehabilitation cancer rehabilitation clinics were administered the PROMIS® Cancer Function Brief 3D Profile to evaluate function in the domains of physical function, fatigue, and social participation. Clinical and demographic information, including treatment history and disease status, was recorded by clinicians. Patients were analyzed in two groups: those with active disease on antineoplastic treatment, and those with no evidence of disease (NED). A multivariable model was constructed to detect associations between clinical and demographic factors.
Results
In patients with NED, the presence of chemotherapy-induced peripheral neuropathy (CIPN) was strongly associated with reduced function in all three domains. In those with active disease, having brain metastases was significantly associated with reduced function in all domains and CIPN with reduced physical function. Radiation was associated with improved function in both cohorts.
Conclusions
Among women seeking rehabilitative care, CIPN and the presence of brain metastases were most strongly associated with a decline in function. The effects of radiation on function were unexpected and may be partially explained by the treatment’s role in symptom management. Clinicians who treat breast cancer should consider a patient’s functional status when providing supportive care.
Similar content being viewed by others
Data availability
Available upon request. Currently curated by the University of Michigan.
References
American Cancer Society (2022) Cancer facts and figures 2022. American Cancer Society, Atlanta
Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW (2014) Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS ONE 9(5):e96748
Cheville AL, Troxel AB, Basford JR, Kornblith AB (2008) Prevalence and treatment patterns of physical impairments in patients with metastatic breast cancer. J Clin Oncol 26(16):2621
Kaya T, Karatepe AG, Günaydn R, Yetiş H, Uslu A (2010) Disability and health-related quality of life after breast cancer surgery: relation to impairments. South Med J 103(1):37–41
Rietman JS, Dijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, Geertzen JH (2003) Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 29(3):229–238
Visnjevac O, Matson B (2013) Postmastectomy pain syndrome: an unrecognized annual billion dollar national financial burden. J Pain 14(4):S33
Kamgar M, Greenwald MK, Assad H, Hastert TA, McLaughlin EM, Reding KW, Paskett ED, Bea JW, Shadyab AH, Neuhouser ML, Nassir R (2021) Prevalence and predictors of peripheral neuropathy after breast cancer treatment. Cancer Med 10(19):6666–6676
Stubblefield MD (2017) Clinical evaluation and management of radiation fibrosis syndrome. Phys Med Rehab Clin 28(1):89–100
Chang PJ, Asher A, Smith SR (2021) A targeted approach to post-mastectomy pain and persistent pain following breast cancer treatment. Cancers 13(20)
Pereira AC, Koifman RJ, Bergmann A (2017) Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. The Breast 1(36):67–73
Juvet LK, Thune I, Elvsaas IØ, Fors EA, Lundgren S, Bertheussen G, Leivseth G, Oldervoll LM (2017) The effect of exercise on fatigue and physical functioning in breast cancer patients during and after treatment and at 6 months follow-up: a meta-analysis. The Breast 1(33):166–177
Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, Schmitz KH (2012) Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer 118(8 Suppl):2237–2249. https://doi.org/10.1002/cncr.27467. (PMID: 22488698)
McNeish BL, Zheutlin AR, Richardson JK, Smith SR (2020) Primary cancer location predicts predominant level of brachial plexopathy. Muscle Nerve 62(3):386–389
Oza S (2021) Aromatase Inhibitor-induced Musculoskeletal Syndrome: a Review of Rehabilitation Interventions. Curr Phys Med Rehabil Rep 9(3):119–126
Smith SR, Vargo M, Zucker D, Shahpar S, Gerber L, Henderson M, Jay G, Lee M, Cheville A (2021) Psychometric characteristics and validity of the PROMIS cancer function brief 3D profile. Arch Phys Med Rehab
Leclerc AF, Foidart-Dessalle M, Tomasella M, Coucke P, Devos M, Bruyère O, Bury T, Deflandre D, Jerusalem G, Lifrange E, Kaux JF (2017) Multidisciplinary rehabilitation program after breast cancer: benefits on physical function, anthropometry and quality of life. Eur J Phys Rehabil Med 53(5):633–642
Sleight AG, Gerber LH, Marshall TF, Livinski A, Alfano CM, Harrington S, Flores AM, Virani A, Hu X, Mitchell SA, Varedi M (2022) A systematic review of functional outcomes in cancer rehabilitation research. Arch Phys Med Rehab
Smith SR, Vargo M, Zucker DS, Henderson M, Shahpar S, Wisotzky EM, Custodio C, Basford J, Jay G, Gerber L, Cheville A (2021) The Cancer Rehabilitation Medicine Metrics Consortium: a path to enhanced, multi-site outcome assessment to enhance care and demonstrate value. Front Oncol 10:625700
Smith SR, Vargo M, Zucker DS, Shahpar S, Gerber LH, Henderson M, Jay G, Cheville AL (2022) Responsiveness and interpretation of the PROMIS Cancer Function Brief 3D profile. Cancer
Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333
Rivera DR, Ganz PA, Weyrich MS, Bandos H, Melnikow J (2018) Chemotherapy-associated peripheral neuropathy in patients with early-stage breast cancer: a systematic review. J Natl Cancer Inst 110(2):140
Park J, Rodriguez JL, O’Brien KM, Nichols HB, Hodgson ME, Weinberg CR, Sandler DP (2021) Health-related quality of life outcomes among breast cancer survivors. Cancer 127(7):1114–1125
Martin AM, Cagney DN, Catalano PJ, Warren LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA, Alexander BM (2017) Brain metastases in newly diagnosed breast cancer: a population-based study. JAMA Oncol 3(8):1069–1077
Fries JF, Bruce B, Cella D (2005) The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 23(5):S53
Pergolotti M, Deal AM, Lavery J, Reeve BB, Muss HB (2015) The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer. J Geriatric Oncol 6(3):194–201
Decoster L, Kenis C, Schallier D, Vansteenkiste J, Nackaerts K, Vanacker L, Vandewalle N, Flamaing J, Lobelle JP, Milisen K, De Greve J (2017) Geriatric assessment and functional decline in older patients with lung cancer. Lung 195(5):619–626
Galvin A, Helmer C, Coureau G, Amadeo B, Rainfray M, Soubeyran P, Dartigues JF, Pérès K, Bellera C, Delva F, Mathoulin-Pélissier S (2019) Determinants of functional decline in older adults experiencing cancer (the INCAPAC study). J Geriatric Oncol 10(6):913–920
Kenis C, Decoster L, Bastin J, Bode H, Van Puyvelde K, De Grève J, Conings G, Fagard K, Flamaing J, Milisen K, Lobelle JP (2017) Functional decline in older patients with cancer receiving chemotherapy: a multicenter prospective study. J Geriatric Oncol 8(3):196–205
Hoppe S, Rainfray M, Fonck M, Hoppenreys L, Blanc JF, Ceccaldi J, Mertens C, Blanc-Bisson C, Imbert Y, Cany L, Vogt L (2013) Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol 31(31):3877–3882
Muhandiramge J, Orchard SG, Warner ET, van Londen GJ, Zalcberg JR (2022) Functional decline in the cancer patient: a review. Cancers 14(6):1368
Cheville AL, Basford JR, Parney I, Yang P, Diehn FE (2017) Nested cohort study to identify characteristics that predict near-term disablement from lung cancer brain metastases. Arch Phys Med Rehabil 98(2):303–311
Acknowledgements
None.
Funding
This study was funded in part by a grant from the Foundation for Physical Medicine and Rehabilitation.
Author information
Authors and Affiliations
Contributions
Conceptualization, methodology, formal analysis, writing, data curation; SRS: conceptualization, methodology, formal analysis, investigation, writing, visualization, supervision, data acquisition, funding acquisition; MV: conceptualization, investigation, data acquisition, writing; DZ: conceptualization, methodology, data acquisition, investigation, writing; BR: statistical analysis, visualization; SS: conceptualization, data acquisition, investigation, writing; LG: conceptualization, methodology, writing; MH: conceptualization, investigation, writing; GJ: validation, data curation, project administration; AC: conceptualization, data acquisition, methodology, writing.
Corresponding author
Ethics declarations
Conflict of interest
This was reviewed with all authors, and there are no relevant financial or commercial conflicts of interest.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee at each institution that participated in data collection.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Stoyles, N., Cheville, A., Zucker, D. et al. Risk factors for reduced function in women with a history of breast cancer. Breast Cancer Res Treat 197, 613–621 (2023). https://doi.org/10.1007/s10549-022-06838-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-022-06838-3